Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis

被引:2
|
作者
Oh, Hong Sang [1 ]
Kim, Joon Ho [2 ]
Woo, Myoung Lyeol [3 ]
Kim, Ji-Yeon [4 ]
Park, Chul Hee [5 ]
Won, Hyejin [6 ]
Lim, Seungkwan [7 ]
Jeong, Hyeonju [7 ,8 ]
Ham, Sin Young [8 ,13 ]
Kim, Eun Jin [9 ]
Sheen, Seungsoo [10 ]
Kang, Yu Min [11 ]
Yoon, Doran [1 ]
Lee, Seung Youp [12 ]
Song, Kyoung-Ho [8 ]
机构
[1] Armed Forces Capital Hosp, Dept Internal Med, Seongnam, South Korea
[2] Uijeongbu Hosp, Gyeonggi Prov Med Ctr, Dept Surg, Uijongbu, South Korea
[3] Uijeongbu Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Uijongbu, South Korea
[4] Seongnam Citizens Med Ctr, Dept Med, Div Infect Dis, Seongnam, South Korea
[5] Icheon Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Icheon, South Korea
[6] Pocheon Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Pochon, South Korea
[7] Ansung Hosp, Gyeonggi Prov Med Ctr, Dept Internal Med, Anseong, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, 82,Gumi Ro 173 Boom Gil, Seongnam 13620, South Korea
[9] Ajou Univ, Sch Med, Dept Infect Dis, Suwon, South Korea
[10] Ajou Univ, Sch Med, Dept Pulm Crit Care Med, Suwon, South Korea
[11] Myongji Hosp, Dept Internal Med, Div Infect Dis, Goyang, South Korea
[12] Ansung Hosp, Gyeonggi Prov Med Ctr, Dept Emergency Med, 95 Nampa Ro, Anseong 11671, South Korea
[13] Vet Hlth Serv Med Ctr, Dept Internal Med, Seoul, South Korea
关键词
COVID-19; SARS-CoV-2; Asymptomatic; Symptom development; Medical resource allocation; CORONAVIRUS DISEASE;
D O I
10.3947/ic.2021.0077
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In preparation for the surge of coronavirus disease 2019 (COVID-19), it is crucial to allocate medical resources efficiently for distinguishing people who remain asymptomatic until the end of the disease. Between January 27, 2020, and April 21, 2020, 517 COVID-19 cases from 13 healthcare facilities in Gyeonggi province, Korea, were identified out of which the epidemiologic and clinical information of 66 asymptomatic patients at the time of diagnosis were analyzed retrospectively. An exposure-diagnosis interval within 7 days and abnormal aspartate aminotransferase levels were identified as characteristic symptom development in asymptomatic COVID-19 patients. If asymptomatic patients without these characteristics at the time of diagnosis could be differentiated early, more medical resources could be secured for mild or moderate cases in this COVID-19 surge.
引用
收藏
页码:786 / 791
页数:6
相关论文
共 50 条
  • [1] COVID-19 clinical and laboratory diagnosis overview
    Zayed, Rania A.
    Omran, Dalia
    Zayed, Abeer A.
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION, 2021, 96 (01):
  • [2] COVID-19 clinical and laboratory diagnosis overview
    Rania A. Zayed
    Dalia Omran
    Abeer A. Zayed
    Journal of the Egyptian Public Health Association, 96
  • [3] Clinical and Laboratory Factors Associated with Severe Disease Course in Turkish Patients with COVID-19 Infection
    Ak, Cagatay
    Sayar, Suleyman
    Polat, Zeynep Pelin
    Kilic, Ebru Tarikci
    Ozdil, Kamil
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2021, 23 (02)
  • [4] Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients
    Han, Huan
    Xu, Zaichao
    Cheng, Xiaoming
    Zhong, Youquan
    Yuan, Li
    Wang, Fubing
    Li, Yan
    Liu, Fang
    Jiang, Yingan
    Zhu, Chengliang
    Xia, Yuchen
    MSPHERE, 2020, 5 (05)
  • [5] Laboratory diagnosis of COVID-19
    Goudouris, Ekaterini S.
    JORNAL DE PEDIATRIA, 2021, 97 (01) : 7 - 12
  • [6] Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients
    Das, Sayoni
    Pearson, Matthew
    Taylor, Krystyna
    Bouchet, Veronique
    Moller, Gert Lykke
    Hall, Taryn O.
    Strivens, Mark
    Tzeng, Kathy T. H.
    Gardner, Steve
    FRONTIERS IN DIGITAL HEALTH, 2021, 3
  • [7] Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients
    Unyaporn Suthutvoravut
    Patratorn Kunakorntham
    Anchisatha Semayai
    Amarit Tansawet
    Oraluck Pattanaprateep
    Pongsathorn Piebpien
    Pawin Numthavaj
    Ammarin Thakkinstian
    Pongsakorn Atiksawedparit
    Cost Effectiveness and Resource Allocation, 21
  • [8] Trajectories of clinical and laboratory characteristics associated with COVID-19 in hemodialysis patients by survival
    Chaudhuri, Sheetal
    Lasky, Rachel
    Jiao, Yue
    Larkin, John
    Monaghan, Caitlin
    Winter, Anke
    Neri, Luca
    Kotanko, Peter
    Hymes, Jeffrey
    Lee, Sangho
    Wang, Yuedong
    Kooman, Jeroen P.
    Maddux, Franklin
    Usvyat, Len
    HEMODIALYSIS INTERNATIONAL, 2022, 26 (01) : 94 - 107
  • [9] Cost-effectiveness analysis of isolation strategies for asymptomatic and mild symptom COVID-19 patients
    Suthutvoravut, Unyaporn
    Kunakorntham, Patratorn
    Semayai, Anchisatha
    Tansawet, Amarit
    Pattanaprateep, Oraluck
    Piebpien, Pongsathorn
    Numthavaj, Pawin
    Thakkinstian, Ammarin
    Atiksawedparit, Pongsakorn
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [10] Factors related to asymptomatic or severe COVID-19 infection
    Perez-Campos Mayoral, Eduardo
    Teresa Hernandez-Huerta, Maria
    Perez-Campos Mayoral, Laura
    Alberto Matias-Cervantes, Carlos
    Mayoral-Andrade, Gabriel
    Laguna Barrios, Luis Angel
    Perez-Campos, Eduardo
    MEDICAL HYPOTHESES, 2020, 144